Canada Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

SUMMARY

Canada Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Canada ophthalmic devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices in Canada

Scope

• The report provides ophthalmic devices information broken down into detailed categories and segments in Canada.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the ophthalmic devices market in Canada.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of the Markets Covered in the Report 11
3.1 Ophthalmic Devices 11
3.2 Cataract Surgery 11
3.2.1 Phacoemulsification Equipment 11
3.2.2 Intra Ocular Lens 11
3.3 Vision Care 11
3.3.1 Ophthalmoscopes 11
3.3.2 Contact lenses 11
3.3.3 Lens care 11
3.3.4 Ophthalmic lens 12
3.3.5 Rigid Gas Permeable Contact Lenses 12
3.4 Refractive Surgery 12
4 Healthcare Sector Review 13
4.1 Healthcare Expenditure 13
4.2 Healthcare Infrastructure 16
4.3 Healthcare Policy 19
5 Regulation System 20
5.1 Medical Equipment Approval Process 20
5.1.1 Classification 20
5.1.2 Conformity Assessment 21
5.1.3 License Fee 23
5.1.4 License Application Processing Duration 23
5.2 Labeling and Packaging 23
5.3 Post-Market Surveillance 24
6 Pricing and Reimbursement 25
7 Distribution Structure 26
7.1 Distribution Structure 26
8 Canada Medical Equipment Cross Market Comparison 27
9 Ophthalmic Devices Cross Country Comparison 29
10 Ophthalmic Devices in Canada 32
10.1 Ophthalmic Devices Overall Revenues by Category (2000-2012) 32
10.2 Ophthalmic Devices Overall Volume by Category (2000-2012) 36
10.3 Ophthalmic Devices Overall Company Share (2006-2007) 38
11 Vision Care in Canada 39
11.1 Vision Care Revenues by Segment (2000-2012) 39
11.2 Vision Care Volume by Segment (2000-2012) 42
11.3 Vision Care Average Price (2000-2012) 43
11.4 Vision Care Distribution Share (2006-2007) 44
11.5 Vision Care Company Share (2006-2007) 45
12 Cataract Surgery in Canada 46
12.1 Cataract Surgery Revenues by Segment (2000-2012) 46
12.2 Cataract Surgery Volume by Segment (2000-2012) 48
12.3 Cataract Surgery Average Price (2000-2012) 49
12.4 Cataract Surgery Distribution Share (2006-2007) 50
12.5 Cataract Surgery Company Share (2006-2007) 51
13 Refractive Surgery in Canada 52
13.1 Refractive Surgery Revenues (2000-2012) 52
13.2 Refractive Surgery Volume (2000-2012) 54
13.3 Refractive Surgery Average Price (2000-2012) 56
13.4 Refractive Surgery Distribution Share (2006-2007) 57
13.5 Refractive Surgery Company Share (2006-2007) 58
14 Alcon, Inc. Company Profile 59
14.1 Company Overview 59
14.2 Value Chain Analysis 59
14.2.1 Manufacturing 60
14.2.2 Product Development 60
14.2.3 Sales and Marketing 61
14.3 Alcon, Inc. Pipeline Products 62
14.3.1 Alcon, Inc. Pipeline Products by Equipment Type 62
14.3.2 Alcon, Inc. Pipeline Products by Development Stage 62
14.3.3 Alcon, Inc. Pipeline Products by Therapy Area 63
14.3.4 Alcon, Inc. Pipeline Products by Clinical Trials 63
15 Bausch & Lomb Incorporated Company Profile 64
15.1 Company Overview 64
15.2 Value Chain Analysis 64
15.2.1 Manufacturing 65
15.2.2 Product Development 65
15.2.3 Sales and Marketing 66
15.3 Bausch & Lomb Incorporated Pipeline Products 67
15.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type 67
15.3.2 Bausch & Lomb Incorporated Pipeline Products by Development Stage 67
15.3.3 Bausch & Lomb Incorporated Pipeline Products by Therapy Area 67
15.3.4 Bausch & Lomb Incorporated Pipeline Products by Clinical Trials 68
15.3.5 Bausch & Lomb Incorporated Pipeline Products by News Summary 68
16 Carl Zeiss AG Company Profile 69
16.1 Company Overview 69
16.2 Value Chain Analysis 69
16.2.1 Manufacturing 70
16.2.2 Product Development 70
16.2.3 Sales and Marketing 71
17 Essilor International Company Profile 72
17.1 Company Overview 72
17.2 Value Chain Analysis 72
17.2.1 Manufacturing 73
17.2.2 Product Development 73
17.2.3 Sales and Marketing 73
18 Johnson & Johnson Vision Care, Inc. Company Profile 74
18.1 Company Overview 74
19 Financial Deals Landscape 75
19.1 Acquisition 75
19.1.1 OPKO Health Acquires Ophthalmic Technologies 75
19.1.2 eXegenics acquire Ophthalmic Technologies 76
19.2 Venture Financing 77
19.2.1 Novadaq Technologies Raises $9 Million In Venture Financing 77
19.3 IPO 79
19.3.1 Occulogix Completes Private Placement Of Common Stock For $10 Million 79
19.3.2 Occulogix Completes IPO 80
19.4 Debt Offerings 81
19.4.1 Angiotech Pharmaceuticals Closes $325 Million Private Placement 81
19.4.2 Angiotech Pharmaceuticals Announces Public Offering Of $84.19 Million 83
19.4.3 Angiotech Pharmaceuticals Announces Public Offering Of $77.7 Million 84
19.4.4 Angiotech Enters Into A Licensing Agreement With Symphony Medical 85
19.4.5 Boston Scientific Enters Into Licensing Agreement With Angiotech Pharmaceuticals 86
20 Appendix 89
20.1 Global Markets Direct Research Methodology 89
20.2 Coverage 90
20.3 Secondary Research 90
20.4 Primary Research 91
20.5 Models 91
20.6 Forecasts 92
20.7 Expert Panels 92
20.8 Currency Conversion 93
20.9 Contact Us 94
20.10 Disclaimer 94

1.1 List of Tables
Table 1: Number of Physicians by Province in Canada, 2001 and 2005 16
Table 2: Hospital Wards by Specialty in Canada, 2003-2007 17
Table 3: Doctors by Specialty in Canada, 2003-2007 18
Table 4: Medical Equipment Classification in Canada, 2007 20
Table 5: Medical Equipment Licensing Fee in Canada, 2007 23
Table 6: Medical Equipment License Processing Duration in Canada, 2007 23
Table 7: Canada, Medical Equipment Market Comparison 28
Table 8: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012 31
Table 9: Ophthalmic Devices, Canada, Category Revenues ($ mn), 2000-2012 32
Table 10: Ophthalmic Devices Market, Canada, Portfolio Analysis 33
Table 11: Ophthalmic Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007 34
Table 12: Ophthalmic Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012 35
Table 13: Ophthalmic Devices, United States, Category Volume (Units), 2000-2012 36
Table 14: Ophthalmic Devices, United States, Category Volume (Units), Historic, 2000-2007 36
Table 15: Ophthalmic Devices, United States, Category Volume (Units), Forecast, 2007-2012 37
Table 16: Ophthalmic Devices, Canada, Overall Company Share by Revenue, 2006-2007 38
Table 17: Vision Care, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 40
Table 18: Vision Care, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 41
Table 19: Vision Care, United States, Volume (Units) by Segment, Historic, 2000-2007 42
Table 20: Vision Care, United States, Volume (Units) by Segment, Forecast, 2007-2012 42
Table 21: Vision Care, Canada, Average Price ($), Historic, 2000-2007 43
Table 22: Vision Care, Canada, Average Price ($), Forecast, 2007-20012 43
Table 23: Vision Care, Canada, Distribution Share by Revenue ($ mn), 2006-2007 44
Table 24: Vision Care, Canada, Company Share by Revenue ($ mn), 2006-2007 45
Table 25: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 46
Table 26: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 47
Table 27: Cataract Surgery, Canada, Volume (Units) by Segment, Historic, 2000-2007 48
Table 28: Cataract Surgery, Canada, Volume (Units) by Segment, Forecast, 2007-2012 48
Table 29: Cataract Surgery, Canada, Average Price ($), Historic, 2000-2007 49
Table 30: Cataract Surgery, Canada, Average Price ($), Forecast, 2007-2012 49
Table 31: Cataract Surgery, Canada, Distribution Share by Revenue ($ mn), 2006-2007 50
Table 32: Cataract Surgery, Canada, Company Share by Revenue ($ mn), 2006-2007 51
Table 33: Refractive Surgery, Canada, Revenues ($ mn), Historic, 2000-2007 52
Table 34: Refractive Surgery, Canada, Revenues ($ mn), Forecast, 2007-2012 53
Table 35: Refractive Surgery, Canada, Volume (Units), Historic, 2000-2007 54
Table 36: Refractive Surgery, Canada, Volume (Units), Forecast, 2007-2012 55
Table 37: Refractive Surgery, Canada, Average Price ($), Historic, 2000-2007 56
Table 38: Refractive Surgery, Canada, Average Price ($), Forecast, 2007-2012 56
Table 39: Refractive Surgery, Canada, Distribution Share by Revenue ($ mn), 2006-2007 57
Table 40: Refractive Surgery, Canada, Company Share by Revenue ($ mn), 2006-2007 58
Table 41: Alcon, Inc. Pipeline Products by Equipment Type 62
Table 42: Alcon, Inc. Pipeline Products By Development Stage 62
Table 43: Alcon, Inc. Pipeline Products By Therapy Area 63
Table 44: Alcon, Inc. Pipeline Products By Clinical Trials 63
Table 45: Bausch & Lomb Incorporated Pipeline Products by Equipment Type 67
Table 46: Bausch & Lomb Incorporated Pipeline Products By Development Stage 67
Table 47: Bausch & Lomb Incorporated Pipeline Products By Therapy Area 67
Table 48: Bausch & Lomb Incorporated Pipeline Products By Clinical Trials 68
Table 49: Bausch & Lomb Incorporated Pipeline Products By News Summaries 68
Table 50: Currency Conversion from USD to Local Currency at 2007 Constant Rate 93

1.2 List of Figures
Figure 1: Healthcare Financing in Canada, 2004 14
Figure 2: Healthcare Expenditure in Canada, 2000 - 2006 15
Figure 3: Canada, Medical Equipment Market Comparison,2007 27
Figure 4: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012 29
Figure 5: Ophthalmic Devices Market, Country Comparison 30
Figure 6: Ophthalmic Devices, Canada, Category Revenues ($ mn), 2000-2012 32
Figure 7: Ophthalmic Devices Market, Canada, Portfolio Analysis 33
Figure 8: Ophthalmic Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007 34
Figure 9: Ophthalmic Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012 35
Figure 10: Ophthalmic Devices, Canada, Overall Company Share (%), 2007 38
Figure 11: Vision Care, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 39
Figure 12: Vision Care, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 41
Figure 13: Vision Care, Canada, Company Share (%), 2007 45
Figure 14: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 46
Figure 15: Cataract Surgery, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 47
Figure 16: Cataract Surgery, Canada, Company Share (%), 2007 51
Figure 17: Refractive Surgery, Canada, Revenues ($ mn), Historic, 2000-2007 52
Figure 18: Refractive Surgery, Canada, Revenues ($ mn), Forecast, 2007-2012 53
Figure 19: Refractive Surgery, Canada, Volume (Units), Historic, 2000-2007 54
Figure 20: Refractive Surgery, Canada, Volume (Units), Forecast, 2007-2012 55
Figure 21: Refractive Surgery, Canada, Company Share (%), 2007 58
Figure 22: Alcon, Inc., Value Chain Analysis 59
Figure 23: Bausch & Lomb Incorporated, Value Chain Analysis 64
Figure 24: Carl Zeiss AG, Value Chain Analysis 69
Figure 25: Essilor International, Value Chain Analysis 72
Figure 26: Global Markets Direct Methodology 89